Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Abu Dzarr Abdullah
Contribution of BCR-ABL Kinase Domain Mutations to Imatinib Mesylate Resistance in Philadelphia Chromosome Positive Malaysian Chronic Myeloid Leukemia Patients
Hematology Reports
Hematology
Related publications
Imatinib Mesylate Resistance Through BCR-ABL Independence in Chronic Myelogenous Leukemia
Cancer Research
Cancer Research
Oncology
Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Expressing P190BCR-Abl.
Internal Medicine
Internal Medicine
Medicine
Result of High-Dose Imatinib Mesylate in Patients With Philadelphia Chromosome--Positive Chronic Myeloid Leukemia After Failure of Interferon-
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Prognostic Significance of Micro RNA 150 Marker in BCR-ABL Positive Chronic Myeloid Leukaemia Patients on Imatinib Mesylate
International Journal of Contemporary Pediatrics
P210 and P190 BCR-ABL Fusion Transcripts Variants Frequencies Among Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Sudan
International Journal of Biomedical Research
The Use of Imatinib Resistance Mutation Analysis to Direct Therapy in Philadelphia Chromosome/BCR-Abl1 Positive Chronic Myeloid Leukaemia Patients Failing Imatinib Treatment, in Patan Hospital, Nepal
British Journal of Haematology
Hematology
BCR-ABL1 Mutations in Patients With Imatinib-Resistant Philadelphia Chromosome-Positive Leukemia by Use of the PCR-Invader Assay
Leukemia Research
Cancer Research
Oncology
Hematology
An Amino-Acid Switch in the BCR-ABL Kinase Domain Modifies Sensitivity to Imatinib Mesylate
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
PECAM-1 Is Involved in BCR/ABL Signaling and May Downregulate Imatinib-Induced Apoptosis of Philadelphia Chromosome-Positive Leukemia Cells
International Journal of Oncology
Cancer Research
Oncology